| Pharmaceutical Information |
| Drug Name |
Clobetasol |
| Drug ID |
BADD_D00489 |
| Description |
Clobetasol is under investigation for the treatment of Scleroderma. Clobetasol has been investigated for the prevention of Psoriasis and Cutaneous Atrophy Due to Corticosteroids. |
| Indications and Usage |
|
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
D07AD01 |
| DrugBank ID |
DB11750
|
| KEGG ID |
D07715
|
| MeSH ID |
D002990
|
| PubChem ID |
5311051
|
| TTD Drug ID |
D0FL5V
|
| NDC Product Code |
Not Available |
| Synonyms |
Clobetasol | Clofenazon | Clobetasol Propionate | Clobetasol 17-Propionate | Clobetasol 17 Propionate | Clobex | Cormax | OLUX | Dermovate | Embeline | Embeline E | Temovate |
|
| Chemical Information |
| Molecular Formula |
C22H28ClFO4 |
| CAS Registry Number |
25122-41-2 |
| SMILES |
CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Induration | 08.01.03.020 | - | - | Not Available | | Infestation | 23.09.05.001; 11.09.01.001 | - | - | Not Available | | Application site burn | 23.03.11.013; 12.07.01.038; 08.02.01.038 | - | - | Not Available |
|
|
|
